var singsData = [{"date":new Date(2012,11,17),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Sandler O'Neill upgrades HCBK to Buy from Hold. Target Price is $9.5.","showOnAxis":false},{"date":new Date(2012,3,10),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Guggenheim maintains HCBK to Neutral. Target Price is $7; previously $6.5.","showOnAxis":false},{"date":new Date(2012,4,14),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Compass Point downgrades HCBK to Neutral from Buy. Target Price is $7.","showOnAxis":false},{"date":new Date(2012,5,4),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"FBR Capital maintains HCBK to Market Perform. Target Price is $6.5; previously $7.","showOnAxis":false},{"date":new Date(2012,6,25),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCBK reports 2012 Q2's earning $0.15 per share  This beats analyst's estimated EPS $0.14.","showOnAxis":false},{"date":new Date(2012,6,31),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Guggenheim upgrades HCBK to Buy from Neutral.","showOnAxis":false},{"date":new Date(2012,7,28),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Guggenheim downgrades HCBK to Neutral from Buy.","showOnAxis":false},{"date":new Date(2012,7,28),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"RBC Capital upgrades HCBK to Outperform from Underperform.","showOnAxis":false},{"date":new Date(2012,7,28),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Sterne Agee maintains HCBK to Neutral. Target Price is $93; previously $90.","showOnAxis":false},{"date":new Date(2012,9,18),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Stifel Nicolaus maintains HCBK to Buy. Target Price is $9; previously $8.25.","showOnAxis":false},{"date":new Date(2012,9,23),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Standpoint Research downgrades HCBK to Hold from Buy.","showOnAxis":false},{"date":new Date(2012,9,24),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCBK reports 2012 Q3's earning $0.11 per share  This misses analyst's estimated EPS $0.14.","showOnAxis":false},{"date":new Date(2013,0,30),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, HCBK reports 2012 Q4's earning $0.1 per share  This misses analyst's estimated EPS $0.12.","showOnAxis":false},{"date":new Date(2013,1,19),"type":"sign","text":"R","backgroundColor":"#ADE6C4","graph":"g1","description":"Keefe Bruyette & Woods terminates HCBK coverage  from Market Perform; previously $9.","showOnAxis":false},{"date":new Date(2013,3,30),"type":"sign","text":"E","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, HCBK reports 2013 Q1's earning $0.1 per share  This misses analyst's estimated EPS $0.12.","showOnAxis":false},{"date":new Date(2013,6,18),"type":"arrowDown","text":null,"backgroundColor":"#CC0000","graph":"g1","description":"Sandler O'Neill downgrades HCBK to Hold from Buy.","showOnAxis":false}];